These data seem to suggest that MLANA may be a relatively sensitive and specific marker for melanoma CTCs, and that MLANA levels decay relatively quickly upon removal of the lesion, whereas MIF is associated with a broader spectrum of processes (cancer, inflammation, etc.)and seems to decline on a more protracted time-scale (if at all). The gene discussed is MIF; the disease is melanoma.